Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities

Immune checkpoint blockade using inhibitors of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) has shown clinically significant antitumor response and has been approved for the treatment of malignant melanoma and squamous non-small cell lung cancer (NSCLC). Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transl Lung Cancer Res
Hauptverfasser: Villadolid, Jeryl, Amin, Asim
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2015
Schlagworte:
Review Article on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4630514/
https://ncbi.nlm.nih.gov/pubmed/26629425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2015.06.06
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge